During the past 15 years, the DERC, with its Core Laboratories, Enrichment Program and support for Pilot and Feasibility studies, has played a major role in allowing the expansion in the scope and intensity of research at the Joslin Diabetes Center and Harvard Medical School. The DERC has provided essential support for interdisciplinary studies and junior faculty, and a critical infrastructure for both basic and clinical research. It is not surprising, therefore, that over this period there has been a further evolution and strengthening of the research effort at the Joslin. Recognizing this growth in research activity and the importance of the research mission, the Joslin added additional research space by renovating space previously used for administrative functions. This has resulted in improved laboratory space for individual investigators and the DERC Core Laboratories. In this renewal application, we have attempted to build on our strengths by eliminating Core Laboratories that were underutilized (the Peptide Biochemistry Core), adding new Cores (Flow Cytometry) and restructuring existing Cores including the Advanced Microscopy Core, Radioligand Assay Core (now the Specialized Assay Core), the Genetics Core and the Animal Resources Core (now the Mouse Physiology Core). The Pilot and Feasibility grant program has been expanded to provide larger grants to four scientists and the invitations to compete for these awards have been extended to scientists outside Joslin affiliated with Harvard institutions in the Longwood Area (e.g., Harvard Medical School, Beth Israel Deaconess Medical Center, Brigham and Women's Hospital, Children's Hospital, Dana Farber Cancer Institute, Center for Blood Research). Within the DERC and the Joslin, we have been particularly encouraged over the past five years by the development of the younger faculty who have been supported directly and indirectly by the DERC, such as Drs. Myers, Sharma, Patti, Doria, Stanton and others. These individuals, along with more established investigators, and new recruited faculty including Drs. Christophe Benoist and Diane Mathis, create the scientific base and strength of the DERC. Finally, the strong intellectual stimulus provided by the activities of the Enrichment Program has a major impact, not only at the Joslin, but also in the Harvard-Longwood Medical Area.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Center Core Grants (P30)
Project #
2P30DK036836-16
Application #
6465596
Study Section
Special Emphasis Panel (ZDK1-GRB-D (J2))
Program Officer
Abraham, Kristin M
Project Start
1986-09-30
Project End
2007-03-31
Budget Start
2002-07-01
Budget End
2003-03-31
Support Year
16
Fiscal Year
2002
Total Cost
$2,174,347
Indirect Cost
Name
Joslin Diabetes Center
Department
Type
DUNS #
071723084
City
Boston
State
MA
Country
United States
Zip Code
02215
Karatepe, Kutay; Zhu, Haiyan; Zhang, Xiaoyu et al. (2018) Proteinase 3 Limits the Number of Hematopoietic Stem and Progenitor Cells in Murine Bone Marrow. Stem Cell Reports 11:1092-1105
Sustarsic, Elahu G; Ma, Tao; Lynes, Matthew D et al. (2018) Cardiolipin Synthesis in Brown and Beige Fat Mitochondria Is Essential for Systemic Energy Homeostasis. Cell Metab 28:159-174.e11
Lessard, Sarah J; MacDonald, Tara L; Pathak, Prerana et al. (2018) JNK regulates muscle remodeling via myostatin/SMAD inhibition. Nat Commun 9:3030
Cardamone, Maria Dafne; Tanasa, Bogdan; Cederquist, Carly T et al. (2018) Mitochondrial Retrograde Signaling in Mammals Is Mediated by the Transcriptional Cofactor GPS2 via Direct Mitochondria-to-Nucleus Translocation. Mol Cell 69:757-772.e7
Solheim, Marie H; Winnay, Jonathon N; Batista, Thiago M et al. (2018) Mice Carrying a Dominant-Negative Human PI3K Mutation Are Protected From Obesity and Hepatic Steatosis but Not Diabetes. Diabetes 67:1297-1309
Stanford, Kristin I; Lynes, Matthew D; Takahashi, Hirokazu et al. (2018) 12,13-diHOME: An Exercise-Induced Lipokine that Increases Skeletal Muscle Fatty Acid Uptake. Cell Metab 27:1111-1120.e3
McGill, Dayna E; Volkening, Lisa K; Butler, Deborah A et al. (2018) Baseline Psychosocial Characteristics Predict Frequency of Continuous Glucose Monitoring in Youth with Type 1 Diabetes. Diabetes Technol Ther 20:434-439
Weir, Gordon C; Ehlers, Mario R; Harris, Kristina M et al. (2018) Alpha-1 antitrypsin treatment of new-onset type 1 diabetes: An open-label, phase I clinical trial (RETAIN) to assess safety and pharmacokinetics. Pediatr Diabetes 19:945-954
Qi, Weier; Li, Qian; Gordin, Daniel et al. (2018) Preservation of renal function in chronic diabetes by enhancing glomerular glucose metabolism. J Mol Med (Berl) 96:373-381
Adachi, Yusuke; De Sousa-Coelho, Ana Luisa; Harata, Ikue et al. (2018) l-Alanine activates hepatic AMP-activated protein kinase and modulates systemic glucose metabolism. Mol Metab 17:61-70

Showing the most recent 10 out of 1120 publications